Loading stock data...

Dishman Carbogen Amcis Limited

NSE: DCAL BSE: DCAL

NSE
291.80 -1.35 (-0.46%)

Prev Close

293.15

Open Price

294.8

Volume

350,194

Today Low / High

290.3 / 303

52 WK Low / High

177 / 321.95

Range

277 - 306

BSE
291.75 -1.55 (-0.53%)

Prev Close

293.3

Open Price

293.55

Volume

8,878

Today Low / High

290.25 / 303.15

52 WK Low / High

177.25 / 321.15

Range

277 - 306

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 291.8 (target range: 277 - 306), reflecting a change of -1.35 (-0.46052%). On the BSE, it is listed at 291.75 (target range: 277 - 306), showing a change of -1.55 (-0.52847%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

31 Oct 294.80 0.49%
30 Oct 293.00 0.05%
29 Oct 295.50 -0.85%
28 Oct 293.95 0.44%
27 Oct 285.05 2.91%
24 Oct 282.85 0.37%
23 Oct 291.00 -1.92%
21 Oct 283.70 1.99%
20 Oct 279.50 0.93%
17 Oct 286.85 -2.95%
16 Oct 290.20 -1.15%
15 Oct 278.85 3.96%
14 Oct 292.50 -4.60%
13 Oct 289.90 0.88%
10 Oct 281.10 4.55%
09 Oct 289.95 -2.22%
08 Oct 304.00 -5.76%
07 Oct 291.40 1.42%
06 Oct 282.00 2.04%
03 Oct 278.90 1.85%

Dishman Carbogen Amcis Limited Graph

Dishman Carbogen Amcis Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Dishman Carbogen Amcis Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 291.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 291.75 294.67 265.20 - 324.13
297.59 238.07 - 357.10
300.50 210.35 - 390.65
Bearish Scenario 291.75 288.83 259.95 - 317.72
285.92 228.73 - 343.10
283.00 198.10 - 367.90

Overview of Dishman Carbogen Amcis Limited

ISIN

INE385W01011

Industry

Biotechnology

Vol.Avg

283,388

Market Cap

46,439,152,739

Last Dividend

0

Official Website

Visit Website

IPO Date

2004-04-22

DCF Diff

498.87

DCF

-203

Financial Ratios Every Investor Needs

Stock Dividend of DCAL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2019-09-12 September 12, 19 0.2 0.2 2019-09-13 2019-10-24 2019-05-15
2017-02-17 February 17, 17 1.2 1.2 2017-02-21 2017-03-01
2016-03-17 March 17, 16 1 2
2015-09-10 September 10, 15 1 2
2014-08-21 August 21, 14 0.6 1.2

Stock Rating Details for DCAL

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 2 Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,711.50 Cr 501.65 Cr 2,209.85 Cr 0.8150 0.00 Cr 1,296.17 Cr 175.20 Cr 3.24 Cr 0.21 472.51 Cr 0.0012
2024-03-31 2,615.77 Cr 771.16 Cr 1,844.61 Cr 0.7052 12.98 Cr 114.42 Cr -80.28 Cr -153.45 Cr -9.79 307.18 Cr -0.0587
2023-03-31 2,315.05 Cr 534.21 Cr 1,780.84 Cr 0.7692 0.00 Cr 100.34 Cr 105.49 Cr -29.80 Cr -1.90 307.62 Cr -0.0129
2022-03-31 2,140.68 Cr 458.88 Cr 1,681.80 Cr 0.7856 13.90 Cr 72.16 Cr 29.85 Cr 18.01 Cr 1.15 342.56 Cr 0.0084
2021-03-31 1,912.03 Cr 484.09 Cr 1,427.94 Cr 0.7468 6.50 Cr 63.09 Cr -12.35 Cr -165.13 Cr -10.53 286.42 Cr -0.0864

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 507.03 Cr 9,999.15 Cr 4,167.63 Cr 5,831.5200 Cr 2,388.95 Cr 1,881.92 Cr 900.24 Cr 3,171.08 Cr 0.00 Cr 0.00 Cr 104.08 Cr 1,924.7900 Cr
2024-03-31 264.09 Cr 9,581.41 Cr 3,953.91 Cr 5,627.5000 Cr 2,312.60 Cr 2,048.51 Cr 882.89 Cr 3,236.14 Cr 0.00 Cr 446.38 Cr 8.57 Cr 2,554.7200 Cr
2023-03-31 131.79 Cr 9,453.50 Cr 3,643.83 Cr 5,809.6700 Cr 2,208.85 Cr 2,077.06 Cr 803.80 Cr 3,234.70 Cr 429.65 Cr 165.12 Cr -131.56 Cr 1,798.3900 Cr
2022-03-31 110.24 Cr 8,637.45 Cr 3,088.51 Cr 5,548.9400 Cr 1,829.89 Cr 1,719.65 Cr 645.12 Cr 2,786.88 Cr 294.58 Cr 126.50 Cr -312.27 Cr 1,419.7900 Cr
2021-03-31 243.54 Cr 8,366.10 Cr 2,667.28 Cr 5,698.8200 Cr 1,588.85 Cr 1,345.31 Cr 515.65 Cr 2,628.09 Cr 0.00 Cr -0.01 Cr -131.20 Cr 1,290.2900 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 375.2300 Cr -192.2100 Cr -102.0900 Cr 158.4700 Cr 76.9800 Cr 341.0700 Cr -216.7600 Cr 19.3100 Cr 78.7900 Cr 0.0000 Cr -24.4700 Cr
2024-03-31 383.9700 Cr -229.5200 Cr -22.1500 Cr 80.7200 Cr 132.3000 Cr 264.0900 Cr -303.2500 Cr -153.4500 Cr 119.2600 Cr 0.0000 Cr -85.2400 Cr
2023-03-31 265.9500 Cr -494.0800 Cr 249.6700 Cr -353.7300 Cr 21.5500 Cr 131.7900 Cr -619.6800 Cr -54.5900 Cr 354.9100 Cr 0.0000 Cr -158.6800 Cr
2022-03-31 354.8500 Cr -618.5300 Cr 130.3700 Cr -108.9500 Cr -133.3000 Cr 110.2400 Cr -463.8000 Cr -4.2500 Cr 216.8200 Cr 0.0000 Cr -143.3000 Cr
2021-03-31 512.6600 Cr -380.7900 Cr -11.0400 Cr 146.6300 Cr 121.6000 Cr 243.5400 Cr -366.0300 Cr -65.0300 Cr 102.4600 Cr 0.0000 Cr 90.9100 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 708.05 Cr 98.09 Cr 609.96 Cr 0.8615 59.33 Cr 23.41 Cr 1.49 162.78 Cr 0.0331
2025-03-31 716.34 Cr 145.91 Cr 570.43 Cr 0.7963 73.60 Cr 43.09 Cr 2.75 148.91 Cr 0.0602
2024-12-31 682.34 Cr 98.83 Cr 583.51 Cr 0.8552 68.16 Cr 4.63 Cr 0.30 147.80 Cr 0.0068
2024-09-30 789.04 Cr 190.56 Cr 598.48 Cr 0.7585 75.06 Cr 33.09 Cr 2.11 150.84 Cr 0.0419
2024-06-30 523.78 Cr 454.18 Cr 457.43 Cr 0.8733 -41.62 Cr -77.57 Cr -4.95 24.96 Cr -0.1481

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 532.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -5,831.52 Cr
2025-03-31 507.03 Cr 25.43 Cr 532.46 Cr 668.77 Cr 900.24 Cr 2,200.42 Cr 3,171.08 Cr 9,999.15 Cr 4,167.63 Cr
2024-12-31 0.00 Cr 0.00 Cr 416.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -5,736.76 Cr
2024-09-30 228.40 Cr 24.70 Cr 430.49 Cr 710.03 Cr 903.90 Cr 2,144.44 Cr 3,320.22 Cr 10,180.45 Cr 4,443.69 Cr
2024-06-30 0.00 Cr 0.00 Cr 436.64 Cr 0.00 Cr 0.00 Cr 436.64 Cr 0.00 Cr 0.00 Cr -5,627.50 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 23.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 43.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 4.63 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 33.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -77.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2016-05-02 May 02, 16 2:1
2005-10-21 October 21, 05 5:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹372.10 ₹496,781,777,367.00 ₹2,111,938.00
Anthem Biosciences Ltd. ANTHEM ₹710.10 ₹398,799,297,215.00 ₹343,569.00
Piramal Pharma Limited PPLPHARMA ₹199.63 ₹264,339,882,238.00 ₹1,739,695.00
Syngene International Limited SYNGENE ₹650.10 ₹260,939,987,388.00 ₹435,567.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,854.10 ₹212,341,202,986.00 ₹120,757.00
Concord Biotech Limited CONCORDBIO ₹1,443.80 ₹151,044,875,335.00 ₹41,125.00
Blue Jet Healthcare Limited BLUEJET ₹656.40 ₹113,862,704,970.00 ₹212,670.00
Jubilant Ingrevia Limited JUBLINGREA ₹689.95 ₹108,993,347,159.00 ₹251,771.00
Supriya Lifescience Limited SUPRIYA ₹776.90 ₹62,527,087,320.00 ₹1,252,724.00
Zota Health Care Limited ZOTA ₹1,511.00 ₹45,832,641,705.00 ₹42,257.00
Dishman Carbogen Amcis Limited DCAL ₹291.80 ₹45,749,307,121.00 ₹350,194.00

Key Executives

Chief Executive Officer of CARBOGEN AMCIS
Dr. Stephan Fritschi Ph.D.

Gender: Not Specified

Year Born:

Global Chief Financial Officer
Mr. Harshil R. Dalal

Gender: male

Year Born:

GM of Secretarial & Legal
Mr. Dharmesh Desai

Gender: male

Year Born:

Chief Executive Officer of Projects & Operations
Dr. Himani S. Dhotre

Gender: Not Specified

Year Born:

Whole Time Director
Ms. Deohooti Janmejay Vyas

Gender: female

Year Born: 1951

Chief Executive Officer of Production
Mr. Jayesh A. Shah

Gender: male

Year Born:

Compliance Officer & Company Secretary
Ms. Shrima Gaurangbhai Dave

Gender: female

Year Born:

Head of ESH
Mr. . Gavin

Gender: male

Year Born:

Chief Operating Officer of Indian Operations
Mr. Paolo Armanino

Gender: male

Year Born:

Global MD & Director
Mr. Arpit Janmejay Vyas

Gender: male

Year Born: 1986

FAQs about Dishman Carbogen Amcis Limited

Who is the CEO of the company?

The CEO is Himani S. Dhotre.

What is the current market price of the stock?

The current price is ₹296.20.

What is the 52-week price range?

The range is ₹177-321.95.

What is the market capitalization of the company?

The market capitalization is ₹4,643.92 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 44.65.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Dishman Carbogen Amcis Limited (ISIN: INE385W01011) is a leading Biotechnology in India. With a market capitalization of ₹4,643.92 crores and an average daily volume of 283,388 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.